Patients with lower expression of PD-L1 showed a trend towards better survival; that, however, was not statistically significant (31.5 months versus 16.2, p = 0.24) [ 46 ].
← all excerpts
Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach.
1
—
—